Guang-Biao Zhou Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

2/2024	CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer.
3/2022	Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells.
1/2022	Mutations and clinical significance of calcium voltage-gated channel subunit alpha 1E (CACNA1E) in non-small cell lung cancer.
1/2022	Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1.
3/2020	Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis.
10/2018	Genome-wide identification of transcription factors that are critical to non-small cell lung cancer.
1/2018	Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung Cancer.
1/2017	Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
4/2014	Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer.
1/2012	Gefitinib analogue V1801 induces apoptosis of T790M EGFR-harboring lung cancer cells by up-regulation of the BH-3 only protein Noxa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guang-Biao Zhou Research Topics

Disease

40	Neoplasms (Cancer) 04/2024 - 02/2005
21	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2011
12	Leukemia 08/2012 - 01/2005
11	Acute Promyelocytic Leukemia 08/2012 - 01/2005
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2012
10	Carcinogenesis 01/2022 - 06/2015
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 02/2005
3	Multiple Myeloma 12/2013 - 01/2011
3	Carcinoma (Carcinomatosis) 09/2012 - 03/2009
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2012 - 02/2005
2	Genomic Instability 04/2024 - 07/2015
2	Disease Progression 01/2019 - 01/2005
2	Adenocarcinoma of Lung 01/2018 - 11/2017
2	Hematologic Neoplasms (Hematological Malignancy) 04/2012 - 06/2011
2	Body Weight (Weight, Body) 07/2009 - 04/2007
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024
1	Lymphoma (Lymphomas) 05/2023
1	COVID-19 11/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Dizziness (Lightheadedness) 11/2021
1	Thalassemia 11/2021
1	Exanthema (Rash) 11/2021
1	Fatigue 11/2021
1	Fever (Fevers) 11/2021
1	Pharyngitis (Sore Throat) 11/2021
1	Ovarian Neoplasms (Ovarian Cancer) 02/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2005
7	SmokeIBA 01/2022 - 07/2015
6	CarcinogensIBA 11/2021 - 07/2015
6	Oncogene Proteins (Oncogene Protein)IBA 03/2020 - 01/2007
6	ArsenicIBA 04/2012 - 01/2005
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2011 - 01/2005
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	Imatinib Mesylate (Gleevec)FDA Link 02/2012 - 01/2005
4	Transcription Factors (Transcription Factor)IBA 11/2022 - 01/2007
4	Cisplatin (Platino)FDA LinkGeneric 02/2018 - 01/2012
4	Coal (Coals)IBA 09/2016 - 06/2015
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
3	Benzo(a)pyreneIBA 11/2021 - 11/2015
3	ErbB Receptors (EGF Receptor)IBA 03/2020 - 01/2012
3	celastrolIBA 01/2019 - 04/2014
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 02/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 07/2015
2	Adenosine Triphosphate (ATP)IBA 04/2024 - 01/2012
2	LigandsIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 07/2015
2	ChemokinesIBA 01/2021 - 07/2015
2	UbiquitinIBA 03/2020 - 01/2016
2	largazoleIBA 01/2020 - 10/2013
2	Therapeutic UsesIBA 01/2019 - 06/2011
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2019 - 02/2014
2	Small Interfering RNA (siRNA)IBA 10/2018 - 01/2011
2	6-O-angeloylprenolinIBA 01/2017 - 01/2011
2	Ligases (Synthetase)IBA 01/2016 - 10/2015
2	AA005IBA 04/2014 - 01/2012
2	bigelovinIBA 12/2013 - 06/2009
2	Gefitinib (Iressa)FDA Link 09/2012 - 01/2012
2	oridoninIBA 03/2012 - 04/2007
2	Tyrosine Kinase InhibitorsIBA 02/2012 - 01/2007
2	Arsenic Trioxide (Trisenox)FDA Link 03/2009 - 01/2007
2	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2007 - 01/2005
1	Glucose (Dextrose)FDA LinkGeneric 02/2024
1	Monoclonal AntibodiesIBA 05/2023
1	Immunoglobulin G (IgG)IBA 05/2023
1	Immunoglobulins (Immunoglobulin)IBA 05/2023
1	Angiotensin-Converting Enzyme 2IBA 11/2022
1	QuinolonesIBA 03/2022
1	ProdrugsIBA 03/2022
1	ParaffinIBA 01/2022
1	CalciumIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	KynurenineIBA 01/2022
1	R-Type Calcium Channels (R-Type Calcium Channel)IBA 01/2022
1	CXC ChemokinesIBA 01/2022
1	AntibodiesIBA 01/2022
1	Dextrans (Dextran)FDA Link 11/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2021
1	AzoxymethaneIBA 11/2021
1	Thalidomide (Thalomid)FDA Link 11/2021
1	GlobinsIBA 11/2021
1	Ursolic AcidIBA 11/2020
1	Trace Elements (Biometals)IBA 12/2019
1	ResveratrolIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Ellagic AcidIBA 01/2019
1	PolyphenolsIBA 01/2019
1	fu-yuanIBA 02/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2017
1	MethyltransferasesIBA 01/2017
1	GuanineIBA 01/2017
1	CytosineIBA 01/2017
1	Phosphates (Orthophosphate)IBA 01/2017
1	Long Noncoding RNAIBA 09/2016
1	Y-Box-Binding Protein 1IBA 09/2016

Therapy/Procedure

18	Therapeutics 04/2024 - 01/2005
1	Immunotherapy 01/2019